Carlo Salvarani Selected Research

Carlo Salvarani Research Topics

Disease

40	Giant Cell Arteritis (Horton Disease) 08/2022 - 11/2002
32	Vasculitis (Vasculitides) 01/2022 - 04/2004
23	Rheumatoid Arthritis 04/2022 - 06/2006
22	Psoriatic Arthritis 10/2022 - 08/2003
17	Inflammation (Inflammations) 01/2022 - 02/2008
16	COVID-19 10/2022 - 01/2020
15	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 10/2015 - 04/2002
14	Uveitis 10/2022 - 01/2006
14	Ankylosing Spondylitis 01/2022 - 03/2002
12	Takayasu Arteritis (Arteritis, Takayasu's) 11/2022 - 10/2011
12	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2021 - 01/2020
11	Infections 04/2022 - 05/2007
11	Axial Spondyloarthritis 01/2022 - 07/2014
10	Pneumonia (Pneumonitis) 10/2022 - 08/2020
10	Retroperitoneal Fibrosis 03/2017 - 01/2006
9	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2021 - 08/2009
8	Arthritis (Polyarthritis) 02/2022 - 01/2006
8	Pain (Aches) 01/2022 - 03/2002
8	Central Nervous System Vasculitis 04/2020 - 11/2007
7	Necrosis 01/2020 - 01/2008
7	Cerebral Infarction 01/2019 - 11/2007
6	Rheumatic Diseases (Rheumatism) 02/2022 - 12/2007
6	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2021 - 04/2008
5	Headache (Headaches) 01/2022 - 06/2009
5	Churg-Strauss Syndrome (Allergic Angiitis) 01/2022 - 05/2014
5	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022 - 10/2011
4	Systemic Scleroderma (Systemic Sclerosis) 06/2022 - 01/2018
4	Neoplasms (Cancer) 04/2022 - 06/2009
4	Fatigue 01/2022 - 11/2017
4	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 07/2012
4	Idiopathic Pulmonary Fibrosis 06/2021 - 01/2020
4	Connective Tissue Diseases (Connective Tissue Disease) 03/2021 - 02/2020
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2018
4	Autoimmune Diseases (Autoimmune Disease) 09/2020 - 01/2006
4	Sacroiliitis 01/2019 - 03/2002
4	Venous Thrombosis (Deep-Vein Thrombosis) 12/2018 - 04/2004
3	Tuberculosis (Tuberculoses) 04/2022 - 08/2016
3	Non-Radiographic Axial Spondyloarthritis 01/2022 - 02/2015
3	Fever (Fevers) 01/2022 - 05/2016
3	Proteinuria 11/2021 - 01/2018
3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 05/2021 - 01/2018
3	Injection Site Reaction 12/2020 - 06/2009
3	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 06/2015 - 10/2013
3	Cognitive Dysfunction 05/2015 - 11/2007
3	Shoulder Pain 04/2012 - 03/2011
3	Synovitis 02/2012 - 12/2009
3	Body Weight (Weight, Body) 01/2012 - 05/2007
3	Spondylarthropathies 09/2011 - 05/2009
2	Disease Progression 11/2022 - 01/2021
2	Lymphoma (Lymphomas) 10/2022 - 01/2018
2	Skin Ulcer 06/2022 - 04/2020
2	Respiratory Tract Infections (Respiratory Tract Infection) 04/2022 - 06/2009

Drug/Important Bio-Agent (IBA)

29	tocilizumab (atlizumab)FDA Link 11/2022 - 10/2011
25	GlucocorticoidsIBA 10/2022 - 04/2002
22	Biological ProductsIBA 04/2022 - 05/2007
17	Prednisone (Sone)FDA LinkGeneric 01/2022 - 10/2004
15	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2020 - 05/2003
14	Etanercept (Enbrel)FDA Link 01/2022 - 01/2006
13	Infliximab (Remicade)FDA Link 02/2022 - 04/2003
12	Antirheumatic Agents (DMARD)IBA 04/2022 - 08/2003
12	SteroidsIBA 01/2022 - 04/2003
12	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 04/2008
11	C-Reactive ProteinIBA 11/2022 - 02/2006
11	Rituximab (Mabthera)FDA Link 08/2022 - 04/2014
11	Interleukin-6 (Interleukin 6)IBA 11/2020 - 04/2002
10	Adalimumab (Humira)FDA Link 04/2022 - 07/2012
9	Pharmaceutical PreparationsIBA 01/2022 - 02/2015
9	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2020 - 04/2002
8	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2021 - 04/2003
7	Proteins (Proteins, Gene)FDA Link 10/2021 - 09/2008
7	CytokinesIBA 10/2021 - 04/2004
7	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 10/2004
7	GadoliniumIBA 01/2019 - 11/2007
6	AntibodiesIBA 12/2021 - 07/2014
5	Peptides (Polypeptides)IBA 01/2019 - 01/2006
5	Immunosuppressive Agents (Immunosuppressants)IBA 08/2018 - 01/2006
5	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 03/2017 - 08/2008
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2021 - 02/2012
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2020 - 10/2003
4	Amyloid (Amyloid Fibrils)IBA 01/2019 - 03/2002
3	Methylprednisolone FDA LinkGeneric 10/2022 - 09/2021
3	Biosimilar PharmaceuticalsIBA 02/2022 - 01/2020
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 04/2005
3	ixekizumabIBA 11/2021 - 01/2019
3	belimumabIBA 11/2021 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 08/2012
3	Tumor Necrosis Factor InhibitorsIBA 06/2020 - 01/2016
3	golimumab FDA Link 01/2020 - 11/2017
3	InterleukinsIBA 01/2019 - 02/2013
3	Prostaglandins AIBA 01/2018 - 09/2009
3	Monoclonal AntibodiesIBA 01/2018 - 08/2003
3	Interleukin-33IBA 07/2017 - 02/2013
3	CCR5 Receptors (CCR5 Receptor)IBA 09/2013 - 06/2011
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 09/2021
2	Interleukin-22 (IL-22)IBA 08/2022 - 01/2018
2	Creatine Kinase (Creatine Phosphokinase)IBA 04/2022 - 07/2012
2	upadacitinibIBA 04/2022 - 12/2021

Therapy/Procedure

63	Therapeutics 10/2022 - 04/2003
6	Biological Therapy 05/2021 - 05/2009
2	Drug Therapy (Chemotherapy) 10/2022 - 01/2022